首页-
Products -
Others -
Other Targets -
6-chloro-1-ethyl-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
6-chloro-1-ethyl-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
CAS No. 70458-73-0
6-chloro-1-ethyl-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ( —— )
产品货号. M28462 CAS No. 70458-73-0
6-氯-1-乙基-7-(4-甲基哌嗪-1-基)-4-氧代-1,4-二氢喹啉-3-羧酸是一种用作分子结构单元的化合物。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥765 | 有现货 |
|
| 10MG | ¥1150 | 有现货 |
|
| 25MG | ¥1860 | 有现货 |
|
| 50MG | ¥2660 | 有现货 |
|
| 100MG | ¥3492 | 有现货 |
|
| 200MG | ¥4707 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称6-chloro-1-ethyl-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述6-氯-1-乙基-7-(4-甲基哌嗪-1-基)-4-氧代-1,4-二氢喹啉-3-羧酸是一种用作分子结构单元的化合物。
-
产品描述6-chloro-1-ethyl-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid is a compound used as a molecular building block.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体LPA2
-
研究领域——
-
适应症——
化学信息
-
CAS Number70458-73-0
-
分子量349.82
-
分子式C17H20ClN3O3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCCn1cc(C(O)=O)c(=O)c2cc(Cl)c(cc12)N1CCN(C)CC1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
[Sar1, Ile8]-Angiote...
[Sar1, Ile8]-Angiotensin II is a peptide that has multiple effects on vascular smooth muscle, including contraction of normal arteries and hypertrophy or hyperplasia of cultured cells or diseased vessels. The biological activities of angiotensin II antagonists upon basal and angiotensin II-stimulated aldosterone production were evaluated in an isolated canine glomerulosa cell preparation.
-
S-acetyl-PEG2-Boc
S-乙酰基-PEG2-Boc 是一种基于 PEG 的 PROTAC 连接子,可用于 PROTAC 的合成。
-
Elezanumab
Elezanumab (ABT-555; AE12-1Y-QL) 是一种人单克隆抗体,可选择性靶向排斥性引导分子 A (RGMa)。Elezanumab 通过 SMAD1/5/8 通路有效抑制 RGMa 介导的 BMP 信号传导,IC50 约为 97 pM。Elezanumab 促进神经元损伤和脱髓鞘模型中的神经再生和神经保护作用,可结合 N 末端 RGMa、阻断 BMP 信号传导并缺乏 RGMc 交叉反应性。Elezanumab 具有神经再生和神经保护活性,对铁代谢没有影响。
021-51111890
购物车()
sales@molnova.cn

